# IGC Pharma, Inc.: Form 8-K, filed Mar 13, 2024

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2024-03-13
- Accepted by EDGAR: Mar 13, 2024, 09:00 ET
- Period: 2024-03-12
- Accession: 0001185185-24-000233
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000233/igcpharma20240311_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000233/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518524000233/igcpharma20240311_8k.htm

Filed Mar 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001185185-24-000233. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.